Top Markets
#1 Velas Velas +480.91%
#2 Siren Siren +109.58%
#3 NEW X CEO IS BACK NEW X CEO IS BACK +109.20%
#4 Venom Venom +45.46%
#5 Gigachad Gigachad +23.69%
#6 Ontology Ontology +20.18%
#7 Scor Scor +17.06%
#8 Dacxi Dacxi +16.49%
#9 Strategic Oil Supply Strategic Oil Supply +15.04%
#10 TRIA TRIA +14.71%
Coin of the day
Velas Velas
Настройки
Язык
Pусский
Валюта
USD
Тема
Noxopharm Limited Noxopharm Limited

Noxopharm Limited

NOX
Ранг среди акций #17276
Noxopharm Limited, a drug development company, focuses on developing treatment... Noxopharm Limited, a drug development company, focuses on developing treatment options for a range of solid tumor cancers and septic shock in Australia and internationally. It primarily develops Veyonda, which is an adjuvant therapy in chemotherapy and radiotherapy for the treatment of late-stage cancers. The company also develops DARRT program that is in Phase 1b/2a for the treatment of metastatic castration-resistant prostate cancer and other solid tumors; LuPIN with combined therapy of Veyonda and 177Lu-PSMA-617 for the treatment of late-stage prostate cancer; IONIC program with Veyonda, which is combined with the Bristol Myers Squibb checkpoint inhibitor Opdivo for the treatment of various solid tumor types; and chemotherapy enhancement program (CEP) combined with carboplatin for patients with refractory solid tumors in the breast, head and neck, lung, prostate, and ovaries. In addition, it develops NOXCOVID Program, a dose escalation and dose expansion study of NOX66 for the treatment of COVID-19 infection. Further, the company develops programs to treat pancreatic cancer and glioblastoma. Noxopharm Limited has a collaboration with Hudson Institute of Medical Research and The Australian National University for the research and development of therapeutic drug against inflammatory disorders. The company was incorporated in 2015 and is based in Chatswood, Australia.
Цена акции
$0.0416118
Рыночная капитализация
$12.78M
Изменение (1 день)
1.72%
Изменение (1 год)
-22.01%
Страна
AU
Торговля Noxopharm Limited (NOX)

Категория

Healthcare
Количество находящихся в обращении акций Noxopharm Limited (NOX)
Количество акций в обращении на December 2025: 292.24M
Согласно последним финансовым отчетам и цене акций Noxopharm Limited, текущее количество акций в обращении составляет 292.24M. На конец June 2024 у компании было 292.26M акций в обращении. Количество акций в обращении обычно зависит от сплитов и обратного выкупа акций.
История количества акций в обращении Noxopharm Limited (NOX) с 2016 по 2026
Акции в обращении на конец каждого года
Год Акции в обращении Изменить
2026 (TTM) 292.24M -0.08%
2025 292.47M 0.07%
2024 292.26M 0.01%
2023 292.24M 0.35%
2022 291.22M 10.37%
2021 263.85M 90.70%
2020 138.36M 0.15%
2019 138.15M 16.06%
2018 119.03M 35.93%
2017 87.57M 160.94%
2016 33.56M 0.00%
Акции в обращении у аналогичных компаний или конкурентов
Компания Акции в обращении Разница Страна
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 4.45B 1,422.00%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -13.12%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 102.90M -64.79%
US
UCB SA UCB SA
UCB SA
UCB.BR
 190.00M -34.99%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 483.58M 65.47%
AU